Clinical Trials in Tennessee

Showing 16881-16900 of 17,345 trials

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

NCT00681759

The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin

Cardiovascular Disease

AstraZeneca1,836 participantsStarted Jan 2008

Brentwood, Tennessee, United States • Saint-Laurent, Quebec, Canada • Paris, France

SUSPENDEDPhase 129 miles

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

NCT00264472

5 fluorouracil (5 FU), one of the most actively investigated anti-cancer drugs, is rapidly inactivated by the enzyme dihydropyrimidine dehydrogenase (DPD). ADH300004 blocks DPD. This study will test the safety and effects of oral ADH300004 14 hours prior to oral 5 FU in subjects with refractory solid tumors.

Neoplasms

Adherex Technologies, Inc.60 participantsStarted Jan 2006

Nashville, Tennessee, United States

COMPLETEDPhase 1/229 miles

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00088088

This study is for patients who have Stage IIIb or Stage IV NSCLC and have never had chemotherapy before for their disease. The first phase of the study recently completed and for the second phase of the study patients are randomly assigned to receive either paclitaxel and carboplatin or paclitaxel and carboplatin and study drug (STA 4783). Treatment will be every 3 weeks for 6 cycles.

Stage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer

Synta Pharmaceuticals Corp.86 participantsStarted Mar 2004

Jonesboro, Arkansas, United States • Pomona, California, United States • San Francisco, California, United States +16 more locations

An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients

A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Find Trials by Condition in Tennessee

Attain StarFix™ Model 4195 Left Ventricular Lead

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling Glucose

A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

Tolerance of Healthy Term Infants Fed Infant Formulas

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Basiliximab in Moderate to Severe Ulcerative Colitis

Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury

A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

A Study to Evaluate the Safety of a Monovalent Vaccine in Healthy Adults

Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia